Cargando…

Community purchases of antimicrobials during the COVID-19 pandemic in Uganda: An increased risk for antimicrobial resistance

Self-Medication (SM) involves the utilization of medicines to treat self-recognized symptoms or diseases without consultation and the irrational use of over-the-counter drugs. During the COVID-19 pandemic, the lack of definitive treatment led to increased SM. We aimed to estimate the extent of SM fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiragga, Agnes N., Najjemba, Leticia, Galiwango, Ronald, Banturaki, Grace, Munyiwra, Grace, Iwumbwe, Idd, Atwine, James, Ssendiwala, Cedric, Natif, Anthony, Nakanjako, Damalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021632/
https://www.ncbi.nlm.nih.gov/pubmed/36963050
http://dx.doi.org/10.1371/journal.pgph.0001579
_version_ 1784908540507324416
author Kiragga, Agnes N.
Najjemba, Leticia
Galiwango, Ronald
Banturaki, Grace
Munyiwra, Grace
Iwumbwe, Idd
Atwine, James
Ssendiwala, Cedric
Natif, Anthony
Nakanjako, Damalie
author_facet Kiragga, Agnes N.
Najjemba, Leticia
Galiwango, Ronald
Banturaki, Grace
Munyiwra, Grace
Iwumbwe, Idd
Atwine, James
Ssendiwala, Cedric
Natif, Anthony
Nakanjako, Damalie
author_sort Kiragga, Agnes N.
collection PubMed
description Self-Medication (SM) involves the utilization of medicines to treat self-recognized symptoms or diseases without consultation and the irrational use of over-the-counter drugs. During the COVID-19 pandemic, the lack of definitive treatment led to increased SM. We aimed to estimate the extent of SM for drugs used to treat COVID-19 symptoms by collecting data from pharmacy sale records. The study was conducted in Kampala, Uganda, where we extracted data from community pharmacies with functional Electronic Health Records between January 2018 and October 2021 to enable a comparison of pre-and post-COVID-19. The data included the number of clients purchasing the following drugs used to treat COVID-19 and its symptoms: Antibiotics included Azithromycin, Erythromycin, and Ciprofloxacin; Supplements included Zinc and vitamin C, while Corticosteroids included dexamethasone. A negative binomial model was used to estimate the incident rate ratios for each drug to compare the effect of COVID-19 on SM. In the pre- COVID-19 period (1(st) January 2018 to 11(th) March 2020), 19,285 customers purchased antibiotics which included; Azithromycin (n = 6077), Ciprofloxacin (n = 6066) and Erythromycin (n = 997); health supplements including Vitamin C (430) and Zinc (n = 138); and Corticosteroid including Dexamethasone (n = 5577). During the COVID-19 pandemic (from 15(th) March 2020 to the data extraction date in October 2021), we observed a 99% increase in clients purchasing the same drugs. The number of clients purchasing Azithromycin increased by 19.7% to 279, Ciprofloxacin reduced by 58.8% to 96 clients, and those buying Erythromycin similarly reduced by 35.8% to 492 clients. In comparison, there were increases of 170%, 181%, and 377% for Vitamin C, Zinc, and Dexamethasone, respectively. The COVID-19 pandemic underscored the extent of SM in Uganda. We recommend future studies with a representation of data from pharmacies located in rural and urban areas to further study pandemics’ effect on antimicrobials prescriptions, including obtaining pharmacists’ perspectives using mixed methods approaches.
format Online
Article
Text
id pubmed-10021632
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-100216322023-03-17 Community purchases of antimicrobials during the COVID-19 pandemic in Uganda: An increased risk for antimicrobial resistance Kiragga, Agnes N. Najjemba, Leticia Galiwango, Ronald Banturaki, Grace Munyiwra, Grace Iwumbwe, Idd Atwine, James Ssendiwala, Cedric Natif, Anthony Nakanjako, Damalie PLOS Glob Public Health Research Article Self-Medication (SM) involves the utilization of medicines to treat self-recognized symptoms or diseases without consultation and the irrational use of over-the-counter drugs. During the COVID-19 pandemic, the lack of definitive treatment led to increased SM. We aimed to estimate the extent of SM for drugs used to treat COVID-19 symptoms by collecting data from pharmacy sale records. The study was conducted in Kampala, Uganda, where we extracted data from community pharmacies with functional Electronic Health Records between January 2018 and October 2021 to enable a comparison of pre-and post-COVID-19. The data included the number of clients purchasing the following drugs used to treat COVID-19 and its symptoms: Antibiotics included Azithromycin, Erythromycin, and Ciprofloxacin; Supplements included Zinc and vitamin C, while Corticosteroids included dexamethasone. A negative binomial model was used to estimate the incident rate ratios for each drug to compare the effect of COVID-19 on SM. In the pre- COVID-19 period (1(st) January 2018 to 11(th) March 2020), 19,285 customers purchased antibiotics which included; Azithromycin (n = 6077), Ciprofloxacin (n = 6066) and Erythromycin (n = 997); health supplements including Vitamin C (430) and Zinc (n = 138); and Corticosteroid including Dexamethasone (n = 5577). During the COVID-19 pandemic (from 15(th) March 2020 to the data extraction date in October 2021), we observed a 99% increase in clients purchasing the same drugs. The number of clients purchasing Azithromycin increased by 19.7% to 279, Ciprofloxacin reduced by 58.8% to 96 clients, and those buying Erythromycin similarly reduced by 35.8% to 492 clients. In comparison, there were increases of 170%, 181%, and 377% for Vitamin C, Zinc, and Dexamethasone, respectively. The COVID-19 pandemic underscored the extent of SM in Uganda. We recommend future studies with a representation of data from pharmacies located in rural and urban areas to further study pandemics’ effect on antimicrobials prescriptions, including obtaining pharmacists’ perspectives using mixed methods approaches. Public Library of Science 2023-02-23 /pmc/articles/PMC10021632/ /pubmed/36963050 http://dx.doi.org/10.1371/journal.pgph.0001579 Text en © 2023 Kiragga et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kiragga, Agnes N.
Najjemba, Leticia
Galiwango, Ronald
Banturaki, Grace
Munyiwra, Grace
Iwumbwe, Idd
Atwine, James
Ssendiwala, Cedric
Natif, Anthony
Nakanjako, Damalie
Community purchases of antimicrobials during the COVID-19 pandemic in Uganda: An increased risk for antimicrobial resistance
title Community purchases of antimicrobials during the COVID-19 pandemic in Uganda: An increased risk for antimicrobial resistance
title_full Community purchases of antimicrobials during the COVID-19 pandemic in Uganda: An increased risk for antimicrobial resistance
title_fullStr Community purchases of antimicrobials during the COVID-19 pandemic in Uganda: An increased risk for antimicrobial resistance
title_full_unstemmed Community purchases of antimicrobials during the COVID-19 pandemic in Uganda: An increased risk for antimicrobial resistance
title_short Community purchases of antimicrobials during the COVID-19 pandemic in Uganda: An increased risk for antimicrobial resistance
title_sort community purchases of antimicrobials during the covid-19 pandemic in uganda: an increased risk for antimicrobial resistance
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021632/
https://www.ncbi.nlm.nih.gov/pubmed/36963050
http://dx.doi.org/10.1371/journal.pgph.0001579
work_keys_str_mv AT kiraggaagnesn communitypurchasesofantimicrobialsduringthecovid19pandemicinugandaanincreasedriskforantimicrobialresistance
AT najjembaleticia communitypurchasesofantimicrobialsduringthecovid19pandemicinugandaanincreasedriskforantimicrobialresistance
AT galiwangoronald communitypurchasesofantimicrobialsduringthecovid19pandemicinugandaanincreasedriskforantimicrobialresistance
AT banturakigrace communitypurchasesofantimicrobialsduringthecovid19pandemicinugandaanincreasedriskforantimicrobialresistance
AT munyiwragrace communitypurchasesofantimicrobialsduringthecovid19pandemicinugandaanincreasedriskforantimicrobialresistance
AT iwumbweidd communitypurchasesofantimicrobialsduringthecovid19pandemicinugandaanincreasedriskforantimicrobialresistance
AT atwinejames communitypurchasesofantimicrobialsduringthecovid19pandemicinugandaanincreasedriskforantimicrobialresistance
AT ssendiwalacedric communitypurchasesofantimicrobialsduringthecovid19pandemicinugandaanincreasedriskforantimicrobialresistance
AT natifanthony communitypurchasesofantimicrobialsduringthecovid19pandemicinugandaanincreasedriskforantimicrobialresistance
AT nakanjakodamalie communitypurchasesofantimicrobialsduringthecovid19pandemicinugandaanincreasedriskforantimicrobialresistance